21.02.2014 Views

Medical Professionals Version - National Cancer Centre Singapore

Medical Professionals Version - National Cancer Centre Singapore

Medical Professionals Version - National Cancer Centre Singapore

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

PAGE C2<br />

Under The Microscope<br />

SALUBRIS<br />

July / August 2009<br />

ADVANCES IN RADIOTHERAPY<br />

IN THE MANAGEMENT OF<br />

EARLY PROSTATE CANCER<br />

Continued from page C1.<br />

IMAGE GUIDED RADIOTHERAPY<br />

The prostate is a very mobile organ. Its position varies from day to day depending<br />

on the contents in the rectum and bladder. In the past, the uncertainty of the<br />

prostate’s position was dealt with by using larger treatment volumes. But this<br />

would mean a greater volume of normal tissue being irradiated. However, if the<br />

position of the prostate can be determined before each treatment, then smaller<br />

margins can be applied in the treatment volume. Methods of prostate localisation<br />

include ultrasound and the use of fiducial markers implanted within the prostate.<br />

In the latter method, images taken using the treatment machine’s on-board<br />

imaging device are compared with the images obtained during treatment planning.<br />

If the prostate is found to have shifted, then adjustments are made to align the<br />

radiation beam with the organ. This procedure is critical to IMRT as it helps ensure<br />

that the high-dose volume is accurately delivered to the prostate while the smaller<br />

margins required helps reduce the side-effects even when high doses are given.<br />

The most accurate method currently available is Dynamic Targeting Image Guided<br />

Radiotherapy where treatment machines are equipped with an on-board CT<br />

facility which is used to do scans of patients each day before treatment.<br />

These scanned images are the most accurate representation of the shape and<br />

position of a patient’s tumour or involved organ at the time of treatment.<br />

Adjustments based on these images help maximise the dose to the targeted organ<br />

while minimising the damage to the surrounding normal tissues.<br />

Gold fiducial markers have been used in the treatment of prostate cancer here<br />

since 2004 and NCCS installed its first dynamic targeting IGRT machine in 2007.<br />

HORMONES<br />

Prostate cancer is generally a hormone-responsive disease and there is much<br />

experience in the use of hormones in the treatment of advanced or metastatic<br />

disease. There is now also evidence to show that in selected patients the addition<br />

of androgen suppression therapy to radiotherapy improves disease-free survival<br />

and possibly even overall survival.<br />

BRACHYTHERAPY<br />

Brachytherapy is a method of radiation where radioactive seeds are implanted<br />

into the prostate to effect treatment from within. In the past, its use was limited by<br />

the inability to properly implant these radioactive sources into the prostate. With<br />

improvement in technology, we now have good imaging equipment to plan as well<br />

as monitor the placement of the seeds and modern devices which facilitates very<br />

good implantation transperineally with the use of needles.<br />

The advantage of this method of treatment is that much higher radiation doses can<br />

be concentrated in the prostate while sparing the surrounding tissue.<br />

THE FUTURE – CHARGED<br />

PARTICLE IRRADIATION?<br />

Charged particles such as protons<br />

or carbon ions can be focused<br />

even much more highly compared<br />

to photons and have the potential<br />

for even greater relative sparing<br />

of the surrounding normal tissues.<br />

Their biological effectiveness is also<br />

higher than the usual x-rays used in<br />

radiotherapy.<br />

This makes dose escalation to even<br />

higher doses feasible with even<br />

lesser morbidity to surrounding<br />

normal tissues. They, however,<br />

require very expensive facilities<br />

and are available in only very<br />

few research centres around the<br />

world. With the accumulation of<br />

experience from these centres and<br />

hopefully with technology becoming<br />

more affordable with time, it is<br />

hoped that such treatment would<br />

become more widely available for<br />

the treatment of prostate as well as<br />

other cancers in the future.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!